Children Vaccination Market: Overview
Vaccination is the mechanism to strengthen the immune system to fight against specific antigen. It involves injection of antigens which are weaker version of target viruses. These antigens produce antibodies when body is exposed to similar kind of antigens, in future. This is one of easiest way to prepare the body to fight against certain diseases. Most vaccines are given in the developing stage of the immune system.
With rising awareness among people, they are more inclined towards immunization. Medical practitioners prescribe set of vaccines at the time of birth. These vaccines are administered in the early years to fight attack from viral and bacterial diseases. Besides, subsidized cost of vaccines and efforts by government bodies for children’s health, especially in developing countries, has led to surface of dedicated children vaccination programs.
Owing to all the benefits offered by vaccination and awareness among people, vaccination segment is the leading contributor to the overall pharmaceuticals sector. Moving further, since most vaccinations are done at an early age, paediatric use vaccines contribute significantly to the entire vaccination market.
The market report on children vaccination market covers major drivers and trends which are fuelling the growth of the said market. The insights given in the report focus on challenges and threat in the vaccination market, and how it will shape the future growth of the market. Besides, it also discusses the advancements in the vaccines brought by various companies.
Children Vaccination Market: Trends and Opportunities
Various national government bodies in collaboration with international bodies are trying to raise awareness regarding immunizations among people. World Health Organization (WHO) and philanthropic organizations including Bill & Melinda Gates Foundation are supporting research and development of low cost vaccines.
In May 2012, WHO introduced Global Vaccine Action Plan (GVAP) to ensure easy access of immunization worldwide. The plan was authorized by 194 member states of the world health assembly.
Government in various countries are providing subsidized or free of cost vaccination to reduce the risk of respective diseases. Also, government bodies are funding various research and development programmes to develop vaccines for new viruses. Altogether, these factors are translating into opportunities for growth and expansion of children vaccination market.
Children Vaccination Market: Regional Outlook
In North America, government is forming new policies to support vaccination of newborns. Besides, there are also various companies that are trying to develop new vaccines. As a result of all these factors, North America is anticipated to be the leading contributor to children vaccination market in the duration of forecast period (2017-2025). Most probably, Europe will follow North America.
Countries such as India and China are witnessing high birth rate. This, in turn, is fuelling the demand for vaccines in the region. As a result, the children vaccination market is projected to grow in Asia Pacific region.
Children Vaccination Market: Competitive Analysis
Some of the key players in the children vaccination market are Merck & Co., GlaxoSmithKline, Pfizer, Sanofi Pasteur, and Novartis
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.